Seoul
South Korea
6
2024-04-25
3
2024-02-06
These are the the leading inventors for applications assigned to NOVEL PHARMA INC.:
NOVEL PHARMA INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING OR AMELIORATING GM1 GANGLIOSIDOSIS OR MORQUIO SYNDROME B AND ADMINISTRATION METHOD THEREOF
#2 | 2024-01-25 ✅ Patent 11,890,314 granted on 2024-02-06Pharmaceutical composition for treating, preventing or ameliorating spinal muscular atrophy and administration method thereof
#3 | 2023-07-06COMPOSITION FOR TREATMENT OF GLUTARIC ACIDURIA AND ADMINISTRATION METHOD THEREFOR
#4 | 2022-02-24 ✅ Patent 11,975,048 granted on 2024-05-07Long-acting fatty acid-conjugated GnRH derivatives and pharmaceutical compositions containing same
#5 | 2021-02-04LONG-ACTING FATTY ACID-CONJUGATED GnRH DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
#6 | 2020-08-27 ✅ Patent 10,994,018 granted on 2021-05-04Long-acting palmitic acid-conjugated GnRH derivative, and pharmaceutical composition containing same
Also check out NOVEL PHARMA INC.'s (Seoul, South Korea) applicant profile with 4 patent applications submitted.
162253 ⎘